Paul Saladino· MD
we would see how many people have elevated fasting insulin they have subclinical insulin resistance subclinical metabolic dysfunction and then you can start taking action on that
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we would see how many people have elevated fasting insulin they have subclinical insulin resistance subclinical metabolic dysfunction and then you can start taking action on that
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.